Literature DB >> 17118226

The diabetic foot: the importance of biofilms and wound bed preparation.

Stephen C Davis, Lisa Martinez, Robert Kirsner.   

Abstract

Biofilms are ubiquitous and medically important complex structures consisting of microbial-associated cells embedded in self-produced extracellular matrix of hydrated extrapolymeric substances, which are irreversibly attached to a biological or nonbiological surface. Bacteria that reside as biofilms are resistant to traditional therapy. This alternative community in which microbes exist has recently attracted interest as a potential reason why chronic wounds do not heal. This may be especially important for diabetic foot ulcers, which are often characterized by their refractory nature, their predisposition to have associated underlying infection, and their improvement with débridement. Animal and in vitro models have been developed to better study biofilms, which will allow a venue for therapeutic intervention. Potential opportunities exist that include prevention of bacterial attachment, prevention of biofilm formation, disruption of the biofilm to allow penetration of topical antimicrobial agents, interference with quorum sensing, and enhancement of bacteria dispersion from biofilms to a more easily destroyed planktonic state.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17118226     DOI: 10.1007/s11892-006-0076-x

Source DB:  PubMed          Journal:  Curr Diab Rep        ISSN: 1534-4827            Impact factor:   4.810


  46 in total

1.  A component of innate immunity prevents bacterial biofilm development.

Authors:  Pradeep K Singh; Matthew R Parsek; E Peter Greenberg; Michael J Welsh
Journal:  Nature       Date:  2002-05-30       Impact factor: 49.962

Review 2.  Lactoferrin functions: current status and perspectives.

Authors:  Piera Valenti; Francesca Berlutti; Maria Pia Conte; Catia Longhi; Lucilla Seganti
Journal:  J Clin Gastroenterol       Date:  2004-07       Impact factor: 3.062

3.  Diagnosis and treatment of diabetic foot infections.

Authors:  Benjamin A Lipsky; Anthony R Berendt; H Gunner Deery; John M Embil; Warren S Joseph; Adolf W Karchmer; Jack L LeFrock; Daniel P Lew; Jon T Mader; Carl Norden; James S Tan
Journal:  Plast Reconstr Surg       Date:  2006-06       Impact factor: 4.730

Review 4.  Silver based wound dressings and topical agents for treating diabetic foot ulcers.

Authors:  S M Bergin; P Wraight
Journal:  Cochrane Database Syst Rev       Date:  2006-01-25

5.  Effects of a high-molecular-weight cranberry fraction on growth, biofilm formation and adherence of Porphyromonas gingivalis.

Authors:  Julie Labrecque; Charles Bodet; Fatiha Chandad; Daniel Grenier
Journal:  J Antimicrob Chemother       Date:  2006-05-30       Impact factor: 5.790

6.  Dose-dependent hyperbaric oxygen stimulation of human fibroblast proliferation.

Authors:  K Brismar; F Lind; G Kratz
Journal:  Wound Repair Regen       Date:  1997 Apr-Jun       Impact factor: 3.617

7.  Early experience using low-frequency ultrasound in chronic wounds.

Authors:  Karl H Breuing; Lauren Bayer; Jennifer Neuwalder; Dennis P Orgill
Journal:  Ann Plast Surg       Date:  2005-08       Impact factor: 1.539

8.  Over-the-counter topical antimicrobials: effective treatments?

Authors:  Stephen C Davis; Alejandro L Cazzaniga; William H Eaglstein; Patricia M Mertz
Journal:  Arch Dermatol Res       Date:  2005-11-11       Impact factor: 3.017

Review 9.  The burden of diabetic foot ulcers.

Authors:  G E Reiber; B A Lipsky; G W Gibbons
Journal:  Am J Surg       Date:  1998-08       Impact factor: 2.565

Review 10.  Bacterial small-molecule signaling pathways.

Authors:  Andrew Camilli; Bonnie L Bassler
Journal:  Science       Date:  2006-02-24       Impact factor: 47.728

View more
  25 in total

1.  Assessing bacterial burden in wounds: comparing clinical observation and wound swabs.

Authors:  Charne Nicole Miller; Keryln Carville; Nelly Newall; Suzanne Kapp; Gill Lewin; Leila Karimi; Nick Santamaria
Journal:  Int Wound J       Date:  2010-11-16       Impact factor: 3.315

Review 2.  Vacuum-assisted closure home care training: a process to link education to improved patient outcomes.

Authors:  Kevin Y Woo; R Gary Sibbald
Journal:  Int Wound J       Date:  2008-06       Impact factor: 3.315

3.  Biomedical evaluation of a novel nitrogen oxides releasing wound dressing.

Authors:  Rachna N Dave; Hiren M Joshi; Vayalam P Venugopalan
Journal:  J Mater Sci Mater Med       Date:  2012-09-22       Impact factor: 3.896

4.  Next science wound gel technology, a novel agent that inhibits biofilm development by gram-positive and gram-negative wound pathogens.

Authors:  Kyle G Miller; Phat L Tran; Cecily L Haley; Cassandra Kruzek; Jane A Colmer-Hamood; Matt Myntti; Abdul N Hamood
Journal:  Antimicrob Agents Chemother       Date:  2014-03-17       Impact factor: 5.191

5.  Biofilm formation by Staphylococcus aureus isolates from skin and soft tissue infections.

Authors:  Jakub Kwiecinski; Gunnar Kahlmeter; Tao Jin
Journal:  Curr Microbiol       Date:  2015-01-14       Impact factor: 2.188

6.  [Diabetic foot syndrome].

Authors:  R Lobmann
Journal:  Internist (Berl)       Date:  2011-05       Impact factor: 0.743

Review 7.  Human acellular dermal wound matrix: evidence and experience.

Authors:  Robert S Kirsner; Greg Bohn; Vickie R Driver; Joseph L Mills; Lillian B Nanney; Marie L Williams; Stephanie C Wu
Journal:  Int Wound J       Date:  2013-11-28       Impact factor: 3.315

8.  Anti-biofilm efficacy of nitric oxide-releasing silica nanoparticles.

Authors:  Evan M Hetrick; Jae Ho Shin; Heather S Paul; Mark H Schoenfisch
Journal:  Biomaterials       Date:  2009-02-23       Impact factor: 12.479

9.  Loss of viability and induction of apoptosis in human keratinocytes exposed to Staphylococcus aureus biofilms in vitro.

Authors:  Kelly R Kirker; Patrick R Secor; Garth A James; Philip Fleckman; John E Olerud; Philip S Stewart
Journal:  Wound Repair Regen       Date:  2009-08-11       Impact factor: 3.617

Review 10.  Outcome of antimicrobial therapy in documented biofilm-associated infections: a review of the available clinical evidence.

Authors:  Matthew E Falagas; Anastasios M Kapaskelis; Vasilios D Kouranos; Ourania K Kakisi; Zoe Athanassa; Drosos E Karageorgopoulos
Journal:  Drugs       Date:  2009-07-09       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.